Perbedaan Organon Pharma Indonesia Tbk. dan Pelayaran Tamarin Samudra Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Pelayaran Tamarin Samudra Tbk. diperdagangkan di Rp28 (kapitalisasi pasar 1,05 T, volume 24 jam 10,88 jt). Perbedaan utamanya: Pelayaran Tamarin Samudra Tbk. jauh lebih besar — sekitar 10,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TAMU | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,05 T |
Volume | — | 10,88 jt |
Lot | — | 108,83 rb |
Perputaran | — | 300,23 jt |
Harga Rata-rata | — | 27,59 |
Nilai Transaksi | — | 300,23 jt |
Harga Ekuilibrium Indikatif | — | 28 |
Volume Ekuilibrium Indikatif | — | 8,09 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Pelayaran Tamarin Samudra Tbk (the Company) was established based on the Deed of Notary Linda Ibrahim, SH, No. 38 dated August 27, 1998. The company services are include offshore marine support such as chartering, re-chartering and transshipment services of Accommodation Work Barge (AWB), Anchor Handling Towing Supply (AHTS).
Selengkapnya di halaman TAMU →